Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$62.68 - $95.05 $467,592 - $709,073
7,460 New
7,460 $700,000
Q2 2021

Aug 13, 2021

SELL
$93.66 - $139.27 $165,216 - $245,672
-1,764 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$116.57 - $155.01 $191,757 - $254,991
-1,645 Reduced 48.25%
1,764 $232,000
Q4 2020

Feb 12, 2021

BUY
$99.61 - $142.12 $30,779 - $43,915
309 Added 9.97%
3,409 $452,000
Q3 2020

Nov 13, 2020

SELL
$72.92 - $102.01 $7,292 - $10,201
-100 Reduced 3.13%
3,100 $316,000
Q2 2020

Aug 14, 2020

BUY
$55.75 - $92.75 $178,400 - $296,800
3,200 New
3,200 $278,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Caisse De Depot Et Placement Du Quebec Portfolio

Follow Caisse De Depot Et Placement Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.